Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials-Reference-Cited by-同舟云学术

Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: A systematic review of randomised trials

Published:2014-07 Issue:11 Volume:50 Page:1916-1924
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

West T.A.,Kiely B.E.,Stockler M.R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Characterising the castration-resistant prostate cancer population: a systematic review;Kirby;Int J Clin Pract,2011

3. Management of metastatic castration-resistant prostate cancer: recent advances;Mukherji;Drugs,2012

4. Communicating prognosis to patients with metastatic disease: what do they really want to know?;Butow;Support Care Cancer,2002

5. Communicating prognosis in cancer care: a systematic review of the literature;Hagerty;Ann Oncol,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials;Current Medical Research and Opinion;2024-07-13

2. Beyond the median: Estimating survival times for patients starting endocrine therapy for estrogen receptor‐positive, metastatic breast cancer from recent randomized trials;Asia-Pacific Journal of Clinical Oncology;2024-06-16

3. Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy;The Oncologist;2024-05-20

4. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma;Cancer Biomarkers;2023-12-15

5. Accuracy of oncologists’ estimates of expected survival time in advanced cancer;JNCI Cancer Spectrum;2023-10-31